ANIXA BIOSCIENCES
Anixa is a publicly-traded biotechnology company focused on harnessing the body's immune system in the fight against cancer. Anixa's therapeutic portfolio includes a cancer vaccine technology focused on the immunization against ฮฑ-Lactalbumin to prevent triple negative breast cancer (TNBC), as well as a cancer immunotherapy program which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology. The company's diagnostic portfolio consists of Cchekโข, a liquid biopsy technology for early detection of solid tumors based on the body's immune response to the presence of a malignancy. Anixa continually examines emerging technologies in complementary fields for further development and commercialization.
ANIXA BIOSCIENCES
Industry:
Biotechnology Finance Market Research Pharmaceutical Therapeutics
Founded:
1982-01-01
Address:
Melville, New York, United States
Country:
United States
Website Url:
http://www.anixa.com
Total Employee:
1+
Status:
Active
Contact:
6315495974
Total Funding:
34.27 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail GoDaddy DNS Amazon Virginia Region Amazon Sydney Region
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
PBS-Bio
PBS-Bio develops cancer treatment technologies for pre-clinical research to pharmaceutical clients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
National Cancer Institute
National Cancer Institute investment in Grant - Anixa Biosciences
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-07 | Anixa Biosciences Appoints Dr. Pamela Garzone As Chief Development Officer |
Official Site Inspections
http://www.anixa.com Semrush global rank: 7.48 M Semrush visits lastest month: 478
- Host name: ec2-54-208-101-55.compute-1.amazonaws.com
- IP address: 54.208.101.55
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
